Alcami Carolinas Corporation | Alcami | South Carolina | state | 2022 | undisclosed | | grant |
Novo Nordisk US Bio Production Inc | Novo Holdings A/S | New Hampshire | state | 2022 | undisclosed | | tax credit/rebate |
Allergan Inc. | AbbVie | Texas | local | 2012 | undisclosed | | grant |
Pfizer | Pfizer | Tennessee | state | 2021 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2021 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2021 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Pfizer Inc. | Pfizer | West Virginia | state | 2010 | undisclosed | | tax credit/rebate |
Pfizer Inc | Pfizer | West Virginia | state | 2011 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2012 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2012 | undisclosed | | tax credit/rebate |
Pfizer Inc | Pfizer | West Virginia | state | 2012 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2015 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2016 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2017 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2012 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2016 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2018 | undisclosed | | tax credit/rebate |
Mylan Inc. | Viatris | West Virginia | state | 2011 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2012 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2015 | undisclosed | | tax credit/rebate |
Mylan Inc. | Viatris | West Virginia | state | 2010 | undisclosed | | tax credit/rebate |
Mylan Inc. | Viatris | West Virginia | state | 2011 | undisclosed | | tax credit/rebate |
Mylan Inc. | Viatris | West Virginia | state | 2011 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2012 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2012 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2015 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2016 | undisclosed | | tax credit/rebate |
Mylan Inc. | Viatris | West Virginia | state | 2011 | undisclosed | | tax credit/rebate |
Mylan Inc. | Viatris | West Virginia | state | 2011 | undisclosed | | tax credit/rebate |
Mylan Inc. | Viatris | West Virginia | state | 2011 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2015 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2016 | undisclosed | | tax credit/rebate |
Mylan Inc. | Viatris | West Virginia | state | 2011 | undisclosed | | tax credit/rebate |
Mylan Inc. | Viatris | West Virginia | state | 2011 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2012 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2012 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2012 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2013 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2014 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2015 | undisclosed | | tax credit/rebate |
Mylan Inc | Viatris | West Virginia | state | 2016 | undisclosed | | tax credit/rebate |
L. Perrigo Company | Perrigo | Michigan | local | 2021 | undisclosed | | property tax abatement |
Morphotek Inc. | Eisai | Pennsylvania | state | | | $200,000 | loan or bond financing |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $270,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $360,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $450,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2008 | | $450,000 | federal loan or loan guarantee |
Lannett Company, Inc. | Lannett Co. | Pennsylvania | state | | | $500,000 | loan or bond financing |
Novavax, Inc. | Novavax Inc. | Pennsylvania | state | | | $500,000 | loan or bond financing |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2022 | $0 | $800,000 | grant/loan hybrid program |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | | | $815,278 | loan or bond financing |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | | | $1,250,000 | loan or bond financing |
Lannett Company, Inc | Lannett Co. | Pennsylvania | state | | | $1,250,000 | loan or bond financing |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | | $1,500,000 | loan or bond financing |
Cholestech Corporation | Abbott Laboratories | United States | federal | 2007 | | $1,500,000 | federal loan or loan guarantee |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | | $1,500,000 | loan or bond financing |
Lannett Company, Inc. | Lannett Co. | Pennsylvania | state | | | $2,000,000 | loan or bond financing |
Silarx Pharmaceuticals, Inc | Lannett Co. | United States | federal | 2012 | | $2,138,000 | federal loan or loan guarantee |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2013 | | $3,375,000 | federal loan or loan guarantee |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2014 | | $3,375,000 | federal loan or loan guarantee |
Wyeth, Inc. | Pfizer | United States | federal | 2019 | | $3,542,000 | federal loan or loan guarantee |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2015 | | $4,050,000 | federal loan or loan guarantee |
Gilead Sciences, Inc. | Gilead Sciences | United States | federal | 2011 | | $4,500,000 | federal loan or loan guarantee |
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | | | $5,000,000 | loan or bond financing |
PHARMAFORCE INC | Daiichi Sankyo | Ohio | state | 2009 | | $6,000,000 | loan or bond financing |
PHARMAFORCE INC | Daiichi Sankyo | Ohio | state | 2009 | | $6,000,000 | loan or bond financing |
Pfizer, Inc. | Pfizer | Missouri | local | 2017 | | $220,000,000 | loan or bond financing |
Intervet Inc. | Merck | Kansas | state | 2021 | $1,000 | | training reimbursement |
EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2015 | $1,019 | | tax credit/rebate |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2013 | $1,058 | | tax credit/rebate |
BioDelivery Sciences International, Inc. | BioDelivery Sciences International | North Carolina | state | 2018 | $1,141 | | tax credit/rebate |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2014 | $1,144 | | property tax abatement |
Incyte Corporation | Incyte Corp. | Pennsylvania | state | 2018 | $1,157 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2019 | $1,159 | | tax credit/rebate |
Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2005 | $1,205 | | tax credit/rebate |
Astellas Pharma US, Inc. | Astellas Pharma | Maryland | state | 2007 | $1,236 | | tax credit/rebate |
Valmed Pharamaceutical, Inc. | AbbVie | New York | local | 2006 | $1,312 | | tax credit/rebate; property tax abatement |
PFIZER INC | Pfizer | Tennessee | local | 2012 | $1,333 | | property tax abatement |
Amgen USA, Inc. | Amgen | North Carolina | state | 2015 | $1,362 | | tax credit/rebate |
Valmed Parmaceuticals, Inc. | AbbVie | New York | local | 2005 | $1,375 | | tax credit/rebate; property tax abatement |
ICOS CORPORATION | Eli Lilly | Washington | state | 2007 | $1,375 | | tax credit/rebate |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $1,440 | | training reimbursement |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2013 | $1,441 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2012 | $1,480 | | tax credit/rebate |